Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
PUT
C3.ai
AI
$1.64B
| $1.39M | ﹤0.01% |
+30,000
| New | +$1.53M |
|
4277
Sun Life Financial
SLF
$43.8B
| $1.39M | ﹤0.01% |
26,938
-81,651
| -75% | -$4.2M |
|
4278
Imperial Oil
IMO
$63.1B
| $1.39M | ﹤0.01% |
43,947
-31,913
| -42% | -$883K |
|
4279
Ovid Therapeutics
OVID
$547M
| $1.39M | ﹤0.01% |
412,891
-352,759
| -46% | -$1.29M |
|
4280
Harmonic Inc
HLIT
$1.31B
| $1.39M | ﹤0.01% |
158,350
-434,529
| -73% | -$3.89M |
|
4281
Telecom Argentina
TEO
$5.63B
| $1.39M | ﹤0.01% |
279,816
-323,097
| -54% | -$1.66M |
|
4282
Workhorse Group
WKHS
$33.6M
| $1.39M | ﹤0.01% |
60
-188
| -76% | -$5.69M |
|
4283
CALL
Universal Health Services
UHS
$10.1B
| $1.38M | ﹤0.01% |
10,000
-10,000
| -50% | -$1.51M |
|
|
4284
PUT
Universal Health Services
UHS
$10.1B
| $1.38M | ﹤0.01% |
+10,000
| New | +$1.51M |
|
4285
Waldencast
WALD
$172M
| $1.38M | ﹤0.01% |
141,204
-8,922
| -6% | -$87.9K |
|
|
AKIC
4286
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
| $1.38M | ﹤0.01% |
142,190
| – | – |
|
4287
Ranpak Holdings
PACK
$420M
| $1.38M | ﹤0.01% |
+51,576
| New | +$1.45M |
|
4288
Cal-Maine
CALM
$3.75B
| $1.38M | ﹤0.01% |
38,096
+2,520
| +7% | +$89.9K |
|
4289
PUT
Mettler-Toledo International
MTD
$28B
| $1.38M | ﹤0.01% |
+1,000
| New | +$1.51M |
|
|
GIWWU
4290
DELISTED
GigInternational1, Inc. Units
GIWWU
| $1.38M | ﹤0.01% |
134,653
-120,211
| -47% | -$1.23M |
|
|
CSPR
4291
DELISTED
Casper Sleep Inc.
CSPR
| $1.37M | ﹤0.01% |
321,795
-451,638
| -58% | -$2.7M |
|
4292
McEwen Inc
MUX
$1.25B
| $1.37M | ﹤0.01% |
131,976
-183,365
| -58% | -$2.1M |
|
4293
Wabtec
WAB
$49.4B
| $1.37M | ﹤0.01% |
15,925
+268
| +2% | +$23.1K |
|
|
QNGY
4294
CALL
DELISTED
Quanergy Systems, Inc.
QNGY
| $1.37M | ﹤0.01% |
+86,823
| New | +$17.2M |
|
|
GTPBU
4295
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
| $1.37M | ﹤0.01% |
137,687
-835,000
| -86% | -$8.38M |
|
|
VRTV
4296
DELISTED
VERITIV CORPORATION
VRTV
| $1.36M | ﹤0.01% |
15,238
-47,214
| -76% | -$3.61M |
|
|
ADER
4297
DELISTED
26 Capital Acquisition Corp
ADER
| $1.36M | ﹤0.01% |
140,280
+95,000
| +210% | +$922K |
|
4298
CALL
Chewy
CHWY
$9.52B
| $1.36M | ﹤0.01% |
20,000
+10,000
| +100% | +$828K |
|
4299
OneSpan
OSPN
$610M
| $1.36M | ﹤0.01% |
+72,490
| New | +$1.54M |
|
|
GGPIW
4300
CALL
DELISTED
Gores Guggenheim, Inc. Warrant
GGPIW
| $1.36M | ﹤0.01% |
653,763
+373,763
| +133% | +$735K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.